Excluded because of allergy?

in Uncategorized

Ever excluded from school, sports or leisure activities because of food allergy? Ever get special treatment because of food allergy? IFAN are trying to advocate on behalf of all those affected by food allergy in Ireland. Our aim is to promote inclusion and a balanced factual understanding about different types of food allergy. We need to hear from all those with positive and/or negative experiences about how they or their child’s life has been affected.

email info@ifan.ie in confidence

Allergy & Eczema

in Uncategorized

We at IFAN were delighted to collaborate with the Irish Skin Foundation to produce a practical factual information leaflet for parents and patients addressing 20 common issues and correcting misinformation and myths about allergy and eczema.  We hope you’ll find it useful and encourage you to print it for patient and staff use.

You can download a free copy here


Travel Bursary

in Uncategorized

A limited number of travel grants are now being offered by IFAN to members presenting original work, relevant to the field of Food Allergy at an International meeting in 2017

To be eligible for a grant, the applicant must be:

  • The first author of an abstract (in the field of food allergy) accepted to an international meeting.
  • A member of IFAN.

How to apply?

Applicants should provide the following information by email only:

  • Applicant covering letter
    •1 page CV
    •A copy of the accepted abstract
    •A supporting letter from your head of department

Please submit your application by email only to: info@ifan.ie


Those who are awarded a travel grant will receive travel and subsistence costs refunded up to 500EUR on submission of original receipts. Reimbursement will be made as soon as possible within two months after the meeting.

Please note that a travel grant does not include the registration fee or accommodation costs.

IFAN has registered with Lobbying.ie

in Uncategorized

The Regulation of Lobbying legislation is designed to provide information to the public about who is lobbying whom about what.

The Register of Lobbying is maintained by the Standards in Public Office Commission (Standards Commission). In compliance with The Regulation of Lobbying Act, IFAN registered in November 2015.  We have submitted nil returns to date.  www.lobbying.ie

IFAN respond to HPRA communication on the quality of the supply of adrenaline autoinjectors

in Uncategorized

All three devices currently available in Ireland at the present time have unique elements to their delivery.  Patients and carers all have to be trained in advance, in delivery technique.

IFAN believes that merely ensuring that there are enough devices in the country is no longer an acceptable standard. We are a small market and thus a vulnerable market. We strongly believe that the current haphazard supply of AAIs in Ireland is forcing customers to purchase devices that they and other carers have not been trained to use, thus placing patients at risk of not having adrenaline correctly delivered in the event of a life threatening allergic reaction. This could result in a completely avoidable fatality.

Click here to read an extract from the original communication sent to the HPRA on September 2nd 2015.

Response received from the HPRA on October 2nd 2015.

Click here to read IFAN’s reply to the HPRA response on October 12th 2015


Take the kit campaign

in Uncategorized

The UK Anaphylaxis Campaign has created a film that highlights the severity and associated risks of anaphylaxis and the preventable nature of anaphylaxis deaths. Please watch and share.

Adrenaline auto injector access update: Dail question and answer

in Uncategorized

Jerry Buttimer T.D. asked the Minister for Health if he would provide an update on the public consultation commenced regarding easier access to rescue drugs in emergencies (including adrenaline); when consultation will be complete; when actions will be taken following the consultation; and if he will make a statement on the matter.

Read the full q&a here


LEAP study: consensus communication published

in Uncategorized

Nine international professional allergy organisations today e-published a consensus post LEAP study. Its purpose is to “highlight emerging evidence to existing allergy prevention guidelines regarding potential benefits of supporting early, rather than delayed, peanut introduction during the period of complementary food introduction in infants”.  The communication summarises new evidence, comments on how this evidence might affect present guidance for early complementary feeding practices, provides interim guidance regarding early peanut introduction and ends with a rationale for evaluating and applying this policy to a high-risk population.

Read the draft e publication from JACI online here